Genfit

This study tested if adding an experimental drug called VS-01 to standard care could help adults with a sudden, severe worsening of chronic liver failure (ACLF) and fluid buildup in the abdomen. The trial was small, ended early, and compared VS-01 plus standard care to standard c…

This study tested if adding a new treatment called VS-01 to standard care could help patients with severe liver disease who develop brain fog and confusion (overt hepatic encephalopathy). The treatment was delivered directly into the abdomen during a standard fluid-draining proce…